SUPN 8-K 2026-10-19

SUPERNUS PHARMACEUTICALS, INC. (SUPN) 8-K dated 2026-10-19 — accession 0001356576-26-000043. This URL is the filing, not the SUPN hub.

SUPERNUS PHARMACEUTICALS, INC. (SUPN) is a drug manufacturers - specialty & generic company listed on NASDAQ.

SUPN: SECURITIES AND EXCHANGE COMMISSION

Cached items: 2.02. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported SUPN revenue for 2025-12-31 was $719.0M. Net income was -$38.5M. Revenue was up 8.6% from 2024-12-31 to 2025-12-31. SUPN currently screens at market cap $2.53B.

Not investment advice. The SUPN SEC hub lists recent forms. The stock page is the research view.